$369 Million is the total value of DILLON & ASSOCIATES INC's 68 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QCOM | QUALCOMM | $964,000 | +33.9% | 10,595 | 0.0% | 0.26% | +7.9% | |
| NVS | Novartis AG ADS | $756,000 | +6.2% | 8,689 | 0.0% | 0.20% | -14.6% | |
| K | Kellogg | $556,000 | +10.1% | 8,420 | 0.0% | 0.15% | -11.2% | |
| BIIB | Biogen Inc | $362,000 | -15.2% | 1,351 | 0.0% | 0.10% | -31.9% | |
| TGT | Target Corp. | $348,000 | +28.9% | 2,900 | 0.0% | 0.09% | +3.3% | |
| BMY | Bristol-Myers Squibb | $335,000 | +5.3% | 5,684 | 0.0% | 0.09% | -15.0% | |
| UNH | UnitedHealth Group Inc. | $325,000 | +18.6% | 1,100 | 0.0% | 0.09% | -4.3% | |
| NEO | Neogenomics Inc | $248,000 | +10.7% | 8,000 | 0.0% | 0.07% | -10.7% | |
| HBAN | Huntington Bancshares | $113,000 | +11.9% | 12,586 | 0.0% | 0.03% | -8.8% | |
| CLSN | Celsion Corp New | $89,000 | +345.0% | 22,353 | 0.0% | 0.02% | +242.9% | |
| RMTI | Rockwell Medical Tech Inc | $23,000 | 0.0% | 11,494 | 0.0% | 0.01% | -25.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-07-28
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Apple, Inc. | 42 | Q3 2023 | 11.9% |
| Stryker | 42 | Q3 2023 | 6.3% |
| Visa Inc. | 42 | Q3 2023 | 6.5% |
| Abbott Labs | 42 | Q3 2023 | 5.7% |
| Automatic Data Processing | 42 | Q3 2023 | 4.8% |
| PepsiCo | 42 | Q3 2023 | 4.9% |
| Colgate-Palmolive | 42 | Q3 2023 | 5.9% |
| Paychex | 42 | Q3 2023 | 4.3% |
| Air Products | 42 | Q3 2023 | 3.7% |
| Lowe's | 42 | Q3 2023 | 3.9% |
View DILLON & ASSOCIATES INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-30 |
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR/A | 2023-05-02 |
| 13F-HR | 2023-05-01 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-07-26 |
| 13F-HR | 2022-05-06 |
View DILLON & ASSOCIATES INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.